Silgan Holdings Inc. announced that Shawn C. Fabry will serve as Executive Vice President and Chief Financial Officer, effective immediately. Fabry, who has been with Silgan since 2010, led corporate development and oversaw the company’s acquisition of Weener Plastics Holdings B.V. in October 2024 for €838 million (about $910 million). His experience in finance and M&A positions him to guide Silgan through a period of strategic growth and capital deployment.
The company also named Kimberly I. Ulmer as Senior Vice President and Chief Accounting Officer. Ulmer has managed Silgan’s finance and treasury functions for many years and will continue to oversee the company’s accounting and financial reporting responsibilities.
Executive Vice President Robert B. Lewis will retire from his role on March 31, 2026, while remaining on the board. Lewis’s departure is part of Silgan’s long‑term succession plan and reflects the company’s focus on leadership continuity as it pursues new growth initiatives.
Silgan reported Q3 2025 results with net sales of $2.01 billion, a 15% year‑over‑year increase, and net income of $113.3 million, or $1.06 per diluted share. Adjusted earnings per share rose to $1.22, narrowly beating the consensus estimate of $1.21. The beat was driven by strong performance in the Dispensing and Specialty Closures segment, which recorded record adjusted EBIT for the sixth consecutive quarter, and by revenue growth in the Metal Containers segment, largely from higher volumes in the pet‑food market.
Gross profit margin for the quarter was 16.3%, a 0.5‑percentage‑point decline from the 16.8% reported in Q3 2024, reflecting modest pricing pressure and higher raw‑material costs. Operating income margin increased to 9.9% from 9.6% in the same period, as the company’s cost‑control initiatives offset the margin compression in gross profit. Net income margin slipped to 5.6% from 5.7% year‑over‑year, indicating a slight erosion in profitability despite revenue growth.
Silgan’s guidance for the fourth quarter and full year 2025 was lowered. Management now expects Q4 EPS of $0.62–$0.72, compared with the prior consensus of $0.87, and full‑year adjusted EPS of $3.66–$3.76 versus the previous forecast of $3.92. The downgrade reflects lower customer volume forecasts in North American personal and home‑care markets, higher tax rates, and increased interest expense from a recent euro‑bond issuance. The guidance cut signals management’s concern about near‑term demand headwinds, even as it remains confident in 2026 earnings growth driven by the Weener integration and strong performance in fragrance and pet‑food markets.
CEO Adam Greenlee said the leadership changes are “the next step in our continued long‑term succession planning for Silgan” and praised Lewis’s contributions. He added that Silgan’s “portfolio of consumer staple products remains well positioned to outpace growth in our end markets” and that the company is “poised to deliver earnings growth again in 2026 and beyond.”
Silgan continues to return capital to shareholders, declaring a quarterly dividend of $0.20 per share and authorizing a new $500 million stock‑repurchase program. The company’s capital‑deployment strategy underscores its commitment to shareholder value while investing in high‑return growth areas.
The guidance reduction has been a key driver of investor sentiment, as analysts and investors weigh the company’s near‑term challenges against its long‑term growth prospects. The company’s strong Q3 performance, coupled with the strategic benefits of the Weener acquisition, provides a foundation for future earnings, but the lowered outlook highlights the need for continued vigilance in a competitive and cost‑pressured environment.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.